Scholars@Duke
Journal cover image

Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens

Publication ,  Conference
Appel, JZ; Hartwig, MG; Cantu, E; Palmer, SM; Reinsmoen, NL; Davis, RD
Published in: The Journal of Heart and Lung Transplantation
February 2005
Published version (DOI) Publisher Link

Duke Scholars

Matthew Hartwig
Author Matthew Hartwig Surgery, Cardiovascular and Thoracic Surgery
Scott Michael Palmer Jr.
Author Scott Michael Palmer Jr. Medicine, Pulmonary, Allergy, and Critical Care Medicine

Published In

The Journal of Heart and Lung Transplantation

DOI

10.1016/j.healun.2004.11.178

ISSN

1053-2498

Publication Date

February 2005

Volume

24

Issue

2

Start / End Page

S93 / S93

Publisher

Elsevier BV

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Appel, J. Z., Hartwig, M. G., Cantu, E., Palmer, S. M., Reinsmoen, N. L., & Davis, R. D. (2005). Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens. In The Journal of Heart and Lung Transplantation (Vol. 24, pp. S93–S93). Elsevier BV. https://doi.org/10.1016/j.healun.2004.11.178
Appel, J. Z., M. G. Hartwig, E. Cantu, S. M. Palmer, N. L. Reinsmoen, and R. D. Davis. “Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens.” In The Journal of Heart and Lung Transplantation, 24:S93–S93. Elsevier BV, 2005. https://doi.org/10.1016/j.healun.2004.11.178.
Appel JZ, Hartwig MG, Cantu E, Palmer SM, Reinsmoen NL, Davis RD. Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens. In: The Journal of Heart and Lung Transplantation. Elsevier BV; 2005. p. S93–S93.
Appel, J. Z., et al. “Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens.” The Journal of Heart and Lung Transplantation, vol. 24, no. 2, Elsevier BV, 2005, pp. S93–S93. Crossref, doi:10.1016/j.healun.2004.11.178.
Appel JZ, Hartwig MG, Cantu E, Palmer SM, Reinsmoen NL, Davis RD. Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens. The Journal of Heart and Lung Transplantation. Elsevier BV; 2005. p. S93–S93.
Journal cover image

Published In

The Journal of Heart and Lung Transplantation

DOI

10.1016/j.healun.2004.11.178

ISSN

1053-2498

Publication Date

February 2005

Volume

24

Issue

2

Start / End Page

S93 / S93

Publisher

Elsevier BV

Related Subject Headings

  • Surgery
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology